# NuCana Reports Third Quarter 2025 Financial Results and Provides Business Update
Canonical URL: https://biopharmsignal.com/news/NCNA/nucana-reports-third-quarter-2025-financial-results-and-provides-business-update
Ticker: NCNA
Company: NuCana plc
Source: NuCana plc
Published: 2025-11-13 21:01 EST
Original Source URL: https://ir.nucana.com
## Summary

Announced Encouraging Data on both NUC-7738 and NUC-3373 Initial Data from the Expansion Study of NUC-7738 Expected in Q4 2025 with Final Data Expected in 2026 Compliant with All Nasdaq Continued Listing Criteria Well Capitalized with Anticipated Cash Runway into 2029 EDINBURGH, United Kingdom,

## Article Body
Announced Encouraging Data on both NUC-7738 and NUC-3373 Initial Data from the Expansion Study of NUC-7738 Expected in Q4 2025 with Final Data Expected in 2026 Compliant with All Nasdaq Continued Listing Criteria Well Capitalized with Anticipated Cash Runway into 2029 EDINBURGH, United Kingdom,
## Recent Company News
- 2026-06-01 12:00 EST — [NuCana Appoints Ian Webster as Chief Financial Officer](https://biopharmsignal.com/news/NCNA/nucana-appoints-ian-webster-as-chief-financial-officer) — Source: NuCana plc
- 2026-05-14 20:01 EST — [NuCana Reports First Quarter 2026 Financial Results and Provides Business Update](https://biopharmsignal.com/news/NCNA/nucana-reports-first-quarter-2026-financial-results-and-provides-business-update) — Source: NuCana plc
- 2026-03-19 20:01 EST — [NuCana Reports Fourth Quarter and Year-End 2025 Financial Results and Provides Business Update](https://biopharmsignal.com/news/NCNA/nucana-reports-fourth-quarter-and-year-end-2025-financial-results-and-provides-business-update) — Source: NuCana plc
- 2026-01-06 13:00 EST — [NuCana Appoints Theresa Bruce as Chief Operating Officer](https://biopharmsignal.com/news/NCNA/nucana-appoints-theresa-bruce-as-chief-operating-officer) — Source: NuCana plc
- 2025-12-10 13:00 EST — [NuCana Presents Latest Data Demonstrating Clinical Activity and Favorable Safety for NUC-7738 in Patients with PD-1-Resistant Melanoma](https://biopharmsignal.com/news/NCNA/nucana-presents-latest-data-demonstrating-clinical-activity-and-favorable-safety-for-nuc-7738-in-patients-with-pd-1-resistant-melanoma) — Source: NuCana plc
## Related News
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)
- 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance  of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)